Ependymoma - 48 Studies Found
| Recruiting |
: Carboplatin and Bevacizumab for Recurrent Ependymoma :
: 2011-02-11 :
|
| Recruiting |
: Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine :
|
| Withdrawn |
: Photodynamic Therapy in the Treatment of Malignant Intracranial Tumors :
|
| Active, not recruiting |
: Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas :
: 2011-11-17 : |
| Completed |
: Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2 :
|
| Recruiting |
: Everolimus for Children With Recurrent or Progressive Ependymoma : Recurrent Childhood Ependymoma : 2014-05-29 : Drug: Everolimus The recommended dose of Everolimus is 4.5 mg/m2/dose, once daily for up to 2 years, unt |
| Terminated |
: Antineoplaston Therapy in Treating Patients With Ependymoma : Ependymoma : 1999-11-01 : Drug: Antineoplaston therapy (Atengenal + Astugenal) Patients with an ependymoma will receive Antineopla |
| Terminated |
: Ritonavir and Lopinavir in Treating Patients With Progressive or Recurrent High-Grade Glioma :
|
| Not yet recruiting |
: Phase II Pediatric Study With Dabrafenib in HGG Patients :
|
| Not yet recruiting |
: Phase I/II Trial of Safety and Anti-tumor Efficacy of AXL1717(Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas :
: Drug: AXL1717 IGF-1 receptor inhibitor Other Name: p |